Pages that link to "Q34045535"
The following pages link to Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120. (Q34045535):
Displaying 21 items.
- Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 (Q27658449) (← links)
- Contribution of Asparagine Residues to the Stabilization of a Proteinaceous Antigen-Antibody Complex, HyHEL-10-Hen Egg White Lysozyme (Q27658806) (← links)
- Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction (Q27661588) (← links)
- The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4 (Q33312534) (← links)
- Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses In Vivo (Q33855697) (← links)
- Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C. (Q34206171) (← links)
- Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis. (Q34432690) (← links)
- Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18 (Q34934438) (← links)
- Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterolo (Q35024202) (← links)
- A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens (Q35566508) (← links)
- Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus (Q35634404) (← links)
- Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models (Q35743105) (← links)
- The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other CD4bs monoclonal antibodies (Q35799529) (← links)
- Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle (Q36212921) (← links)
- In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120. (Q36529013) (← links)
- Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response (Q36823297) (← links)
- Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors (Q36856960) (← links)
- Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding (Q37179763) (← links)
- Targeting strategies for delivery of anti-HIV drugs (Q38239575) (← links)
- Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy (Q47174470) (← links)
- Design and Characterization of Stabilized Derivatives of Human CD4D12 and CD4D1 (Q56999232) (← links)